The Venture Codex Logo

The Venture Codex

Ascenta Capital

138 S 1st St Ste 110, Lindenhurst, New York, 11757, United States

Overview

Private equity and venture capital firm.

Founded

2023

Deals ยท 12mo

5

Links

WebsiteLinkedIn

Stage focus

Series B
Series C

Geographic focus

Germany
United States

Sector focus

Finance
Financial Services
Venture Capital

Investment portfolio

12rounds
NAMEDATESIZE
Triveni Bio
Jun 2026Led
$65 MSeries C
Angitia Biopharmaceuticals
Feb 2026Participated
$130 MSeries D
Triana Biomedicines
Dec 2025Led
$120 MSeries B
Iambic Therapeutics
Nov 2025Participated
$100 MOther Equity
Tubulis
Oct 2025Participated
$357 MSeries C
Alpha-9 Oncology
Oct 2024Led
$175 MSeries C
OrsoBio
Sep 2024Led
$67 MSeries B
Cardurion Pharmaceuticals
Jul 2024Led
$260 MSeries B
Odyssey Therapeutics
Dec 2023Led
$101 MSeries C
Iambic Therapeutics
Oct 2023Led
$100 MSeries B
ADARx Pharmaceuticals
Aug 2023Participated
$200 MSeries C
ADARx Pharmaceuticals
Jan 2023Led
$46 MSeries B
Triveni Bio
Jun 2026Led
$65 MSeries C
Angitia Biopharmaceuticals
Feb 2026Participated
$130 MSeries D
Triana Biomedicines
Dec 2025Led
$120 MSeries B
Iambic Therapeutics
Nov 2025Participated
$100 MOther Equity
Tubulis
Oct 2025Participated
$357 MSeries C
Alpha-9 Oncology
Oct 2024Led
$175 MSeries C
OrsoBio
Sep 2024Led
$67 MSeries B
Cardurion Pharmaceuticals
Jul 2024Led
$260 MSeries B
Odyssey Therapeutics
Dec 2023Led
$101 MSeries C
Iambic Therapeutics
Oct 2023Led
$100 MSeries B
ADARx Pharmaceuticals
Aug 2023Participated
$200 MSeries C
ADARx Pharmaceuticals
Jan 2023Led
$46 MSeries B
12
Items
Browse all public portfolio deals

Insights

Time horizon

View by

Deal Distribution

Ascenta Capital: 12 funding rounds are recorded in the selected participation categories.All available history.
Ascenta Capital: 12 funding rounds are recorded in the selected participation categories. All available history
Round typeLed dealsParticipated deals
Series B50
Series C+33
Other Equity01

Monthly Deal Activity

Ascenta Capital: 12 deals are recorded across 46 months.All available history.
Ascenta Capital: 12 deals are recorded across 46 months. All available history
MonthDeals
Jan '231
Feb '230
Mar '230
Apr '230
May '230
Jun '230
Jul '230
Aug '231
Sep '230
Oct '231
Nov '230
Dec '231
Jan '240
Feb '240
Mar '240
Apr '240
May '240
Jun '240
Jul '241
Aug '240
Sep '241
Oct '241
Nov '240
Dec '240
Jan '250
Feb '250
Mar '250
Apr '250
May '250
Jun '250
Jul '250
Aug '250
Sep '250
Oct '251
Nov '251
Dec '251
Jan '260
Feb '261
Mar '260
Apr '260
May '260
Jun '261
Jul '260
Aug '260
Sep '260
Oct '260

Sector Breakdown

Ascenta Capital: Health & Life Sciences is the largest displayed sector by deal count (12 deals).All available history.

A deal can appear in multiple sectors, so sector totals may overlap. Capital represents disclosed total round sizes, not fund cheque sizes.

Ascenta Capital: Health & Life Sciences is the largest displayed sector by deal count (12 deals). All available history
SectorDeals
Health & Life Sciences12
AI & Machine Learning2

Deal Size Distribution

Ascenta Capital: 12 rounds have a disclosed size in the displayed size bands.All available history.

Undisclosed round sizes are excluded. Capital represents total round sizes, not fund cheque sizes.

Ascenta Capital: 12 rounds have a disclosed size in the displayed size bands. All available history
Round size band (USD)Deals
<$5M0
$5M-$10M0
$10M-$25M0
$25M-$50M1
$50M-$100M2
$100M-$250M7
$250M-$500M2
$500M-$1B0
$1B+0

Deals By Geography

Ascenta Capital: United States has the largest recorded deal count among the displayed regions (9 deals).All available history.

Top 4 of 4 regions; European countries are grouped as Europe.

Ascenta Capital: United States has the largest recorded deal count among the displayed regions (9 deals). All available history
RegionDeals
United States9
China1
V5t 1m41
Europe1
Ascenta Capital: 20 co-investors are shown, with OrbiMed sharing 5 recorded deals.All available history.

Co-Investors

Bubble size = shared deals

Click a bubble to open that fund in a new tab.

Shows up to 20 co-investors ranked by shared deals. Deals may be shared with multiple funds, so rows overlap. Capital is total round size, not fund cheque size.

Ascenta Capital: 20 co-investors are shown, with OrbiMed sharing 5 recorded deals. All available history
Co-investorShared deals
OrbiMed5
Bain Capital Life Sciences3
Catalio Capital Management3
Frazier Life Sciences3
Invus3
Janus Henderson Investors3
RA Capital Management3
SR One3
Venrock3
Abingworth2
Alexandria Venture Investments2
BlackRock2
BVF Partners2
Deep Track Capital2
Delos Capital2
Digitalis Ventures2
Fidelity Management & Research Company2
Freeflow Ventures2
General Catalyst2
HBM Healthcare Investments2

Investment Strategy

Ascenta Capital: Led accounts for 67% and participating for 33% of round participation.All available history.
Ascenta Capital: Led accounts for 67% and participating for 33% of round participation. All available history
CategoryDeals (count)Share (%)
Led867%
Participating433%
Ascenta Capital: Single-lead accounts for 38% and co-led for 63% of lead dynamics.All available history.
Ascenta Capital: Single-lead accounts for 38% and co-led for 63% of lead dynamics. All available history
CategoryDeals (count)Share (%)
Single-lead338%
Co-led563%

Team

Evan Rachlin
Lorence Kim

Co-Founder and Managing Partner